2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors.

被引：0

作者：

Beckers, TL

Reissmann, T

Schmidt, M

Fiebig, H

Burger, AM

Pongratz, H

Husky, H

Mahboobi, S

机构：

[1] ASTA Medical AG, BU Oncol, Frankfurt, Germany

[2] Oncotest GmbH, Freiburg, Germany

[3] Univ Regensburg, Inst Chem & Pharm, D-8400 Regensburg, Germany

来源：

CLINICAL CANCER RESEARCH | 2001年 / 7卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

770

引用

下载

页码：3808S / 3808S

页数：1

共 50 条

[1] 2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors
Beckers, T
Reissmann, T
Schmidt, M
Burger, AM
Fiebig, HH
Vanhoefer, U
Pongratz, H
Hufsky, H
Hockemeyer, J
Frieser, M
Mahboobi, S
CANCER RESEARCH, 2002, 62 (11) : 3113 - 3119
[2] Discovery of potent and orally active farnesyltransferase (FT) inhibitors.
Tong, YS
Wang, L
Hasvold, L
Leonard, N
Li, TM
Li, Q
Wang, WB
Cohen, J
Gu, WZ
Zhang, HY
Bauch, J
Marsh, K
Rosenberg, SH
Lin, NH
Sham, HL
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U29 - U29
[3] Potent, selective, and orally active second generation COX-2 inhibitors.
Roy, PJ
Brideau, C
Chan, C
Charleson, S
Cromlish, W
Ethier, D
Evans, J
Ford-Hutchinson, A
Greig, G
Gresser, M
Grimm, E
Guay, J
Kargman, S
Leblanc, Y
Li, CS
O'Neill, G
Riendeau, D
Rodger, I
Wang, Z
Wong, E
Xu, L
Young, RN
Zamboni, R
Prasit, P
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U861 - U861
[4] DESIGN AND SYNTHESIS OF NOVEL POTENT, NON-PEPTIDE AND ORALLY ACTIVE RENIN INHIBITORS.
Grutter, M.
Maibaum, J.
Rasetti, V.
Rueger, H.
Goschke, R.
Mah, R.
Cohen, N. C.
Rahuel, J.
Cumin, F.
Wood, J.
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1996, 52 : C583 - C583
[5] Discovery of novel orally efficacious small molecule IL-12 production inhibitors.
Kostik, E
Zhang, SJ
Przewloka, T
Ono, M
Sun, LJ
Wada, Y
Cimmanamada, D
Demko, Z
Tatsuta, N
Liang, GQ
Wang, QF
Zhou, D
Wu, YM
Koya, K
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U963 - U963
[6] Potent and Orally Active Small-Molecule Inhibitors of the MDM2-p53 Interaction
Yu, Shanghai
Qin, Dongguang
Shangary, Sanjeev
Chen, Jianyong
Wang, Guoping
Ding, Ke
McEachern, Donna
Qiu, Su
Nikolovska-Coleska, Zaneta
Miller, Rebecca
Kang, Sanmao
Yang, Dajun
Wang, Shaomeng
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (24) : 7970 - 7973
[7] Discovery of a novel, selective, and orally bioavailable class of aggrecanase inhibitors.
Yao, WQ
Chao, M
Reddy, G
Shi, E
Arner, EC
Pratta, MA
Covington, MB
Tortorella, MD
Magolda, RL
Wasserman, ZR
Wexler, RR
Decicco, CP
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U566 - U566
[8] Potent, orally active and non-emetic phosphodiesterase-4 inhibitors.
Guay, D
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U39 - U40
[9] Design and synthesis of β-sulfone and α-sulfone hydroxamates as potent and orally active MMP inhibitors.
Hockerman, SL
Barta, TE
Becker, DP
Bedell, LJ
Boehm, TL
DeCrescenzo, GA
Freskos, JN
Getman, DP
Li, MH
Carron, CP
Funckes-Shippy, CL
Mehta, PP
Munie, GE
Swearingen, CA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U684 - U684
[10] New class of potent, nonpeptidic, orally active renin inhibitors
Remen, Lubos
Bezencon, Olivier
Boss, Christoph
Bur, Daniel
Corminboeuf, Olivier
Grisostomi, Corinna
Richard-Bildstein, Sylvia
Sifferlen, Thierry
Weller, Thomas
Binkert, Christoph
Fischli, Walter
Hess, Patrick
Prade, Lars
Steiner, Beat
Strickner, Panja
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239

← 1 2 3 4 5 →